Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients-Reference-Cited by-同舟云学术

Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients

Published:2014-06-13 Issue:2 Volume:193 Page:580-586
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Palanichamy Arumugam,Jahn Sarah,Nickles Dorothee,Derstine Mia,Abounasr Aya,Hauser Stephen L.,Baranzini Sergio E.,Leppert David,von Büdingen H.-Christian

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial

2. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

3. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma.;Maloney;Blood,1994

4. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

5. Week 144 Results of a Phase II, Randomized, Multicenter Trial Assessing the Safety and Efficacy of Ocrelizumab in Patients with Relapsing–Remitting Multiple Sclerosis (RRMS).;Hauser;Neurology,2013

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and characterization of circulating and adipose tissue infiltrated CD20+ T cells from subjects with obesity that undergo bariatric surgery;Immunology Letters;2024-10

2. Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset;Multiple Sclerosis and Related Disorders;2024-09

3. Current Knowledge about CD3+CD20+ T Cells in Patients with Multiple Sclerosis;International Journal of Molecular Sciences;2024-08-18

4. Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy;Drug Design, Development and Therapy;2024-07

5. Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis;Clinical Immunology;2024-07